Prof Vesa Kataja talks to ecancer at the 2013 SIOG meeting about end-of-life care in relation to the available treatment options.

Prof Kataja also talks about the genetic changes that occur in tumours in younger and in older patients and cause difficulties in choosing the best course of treatment.